The main office of represented Corporate Investor is situated in the Amsterdam. The company was established in Europe in The Netherlands.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Waterline Ventures, Sanofi-Genzyme BioVentures, Qualcomm Ventures.
Among the most popular portfolio startups of the fund, we may highlight Common Sensing. Among the most popular fund investment industries, there are Software, Manufacturing. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
Fund Name | Location |
Arnold Venture Group | Seattle, United States, Washington |
Autodesk | California, San Rafael, United States |
CAM | Japan, Kanagawa Prefecture, Kawasaki |
Central Investments | - |
China Innovation Venture Partners | - |
Defenghao Chuangye Touzi | Chengguan District, China, Lhasa |
DuckDAO | - |
DV Collective | - |
Haolu Touzi | China, Shanghai |
HGTV | Knoxville, Tennessee, United States |
Indosuez Ventures | - |
Japan Infrastructure Initiative Company | Japan, Tokyo |
NetworkAsia Network Services | China, Hong Kong, Hong Kong Island |
New Vista Capital | California, Danville, United States |
OCP Angels | - |
Sanmina Corporation | California, San Jose, United States |
Sofia Capital | Finland, Helsinki, Southern Finland |
Triton Alternative Investment Trust | - |
Venture Gurukool | - |
Wadi Makkah | Makkah, Makkah Region, Saudi Arabia |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Kereos | $19M | 20 Sep 2005 | City of Saint Louis, Missouri, United States |
– BioIntelliSense, Inc. from Denver provides continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM).
– Series B $45m round was led by Chimera (UAE) and joined by 7wire Technology Partners, Mary Tolan of Chicago Pacific Founders, James Murren formerly of MGM Resorts International, as well as Pendrell Corporation, Royal Philips, and Fresenius Medical Care North America.
– The new investment will be used to accelerate the company’s growth and global expansion.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Kereos | $19M | 20 Sep 2005 | City of Saint Louis, Missouri, United States |